BRCA2 c.156_157insAlu Founder Variant in Northern Portugal: An Insight Into Hereditary Breast and Ovarian Cancer Genetic Risk and Management

Documenti analoghi

• Germline PTCH1: c.361_362insAlu alteration identified by comprehensive exome and RNA sequencing in a patient with Gorlin syndrome
  di: Aaron Y. Mochizuki, et al.
  Pubblicazione: (2024)
• Founder Variants of the Turkish
  di: Ahmet Kablan
  Pubblicazione: (2025)
• Prevalence of Germline Variants in Breast, Ovarian, and Prostate Cancer in Uruguay
  di: Victoria Alzogaray
  Pubblicazione: (2026)
• Alu‐Mediated Deletion of FANCA in Turkish Families With Fanconi Anemia: Evidence of a Founder Effect
  di: Ceren Damla Durmaz, et al.
  Pubblicazione: (2024)
• Unique Genetic Profiles in Hypertrophic Cardiomyopathy Patients From São Miguel Island (Azores, Portugal)
  di: Fabiana Duarte, et al.
  Pubblicazione: (2024)